mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |